However, our study already points out that early detection of BCR‐ABL mutation with conventional techniques and accessibility to 2‐3GTKIs have currently reversed the worse outcome of T315I and P‐loop mutated CP‐CML patients. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.